- Home
- NEO vs DEA Comparison
NEO vs DEA Comparison
Compare NEO & DEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- DEA
- Stock Information
- Founded
- NEO 2001
- DEA 2011
- Country
- NEO United States
- DEA United States
- Employees
- NEO N/A
- DEA N/A
- Industry
- NEO Precision Instruments
- DEA Real Estate Investment Trusts
- Sector
- NEO Health Care
- DEA Real Estate
- Exchange
- NEO Nasdaq
- DEA Nasdaq
- Market Cap
- NEO 902.1M
- DEA 912.0M
- IPO Year
- NEO 1999
- DEA 2015
- Fundamental
- Price
- NEO $7.53
- DEA $22.75
- Analyst Decision
- NEO Buy
- DEA Hold
- Analyst Count
- NEO 9
- DEA 4
- Target Price
- NEO $13.31
- DEA $27.69
- AVG Volume (30 Days)
- NEO 2.2M
- DEA 545.9K
- Earning Date
- NEO 07-29-2025
- DEA 07-30-2025
- Dividend Yield
- NEO N/A
- DEA 7.91%
- EPS Growth
- NEO N/A
- DEA N/A
- EPS
- NEO N/A
- DEA 0.41
- Revenue
- NEO $672,361,000.00
- DEA $314,385,000.00
- Revenue This Year
- NEO $13.97
- DEA $7.80
- Revenue Next Year
- NEO $11.36
- DEA $8.44
- P/E Ratio
- NEO N/A
- DEA $55.67
- Revenue Growth
- NEO 10.10
- DEA 6.82
- 52 Week Low
- NEO $6.08
- DEA $19.33
- 52 Week High
- NEO $19.12
- DEA $36.31
- Technical
- Relative Strength Index (RSI)
- NEO 52.96
- DEA 56.90
- Support Level
- NEO $7.04
- DEA $21.91
- Resistance Level
- NEO $7.73
- DEA $22.74
- Average True Range (ATR)
- NEO 0.35
- DEA 0.50
- MACD
- NEO 0.08
- DEA -0.04
- Stochastic Oscillator
- NEO 79.78
- DEA 55.22
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. It is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. The company generates all its revenue by leasing its properties to such agencies.